Assertio Holdings (ASRT) EBT (2019 - 2026)
Assertio Holdings' (ASRT) quarterly EBT came in at -$18.8 million in Q1 2026, down 41.48% year-on-year from -$32.1 million in Q1 2025, and down 60.15% quarter-over-quarter from -$11.7 million in Q4 2025.
Assertio Holdings (ASRT) EBT (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed EBT across 8 years of filings, most recently posting -$18.8 million for Q1 2026.
- EBT for Q1 2026 came in at -$18.8 million, down 41.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$35.5 million (down 16.45% YoY), and the FY2025 annual result was -$29.9 million, down 39.07% from the prior year.
- EBT came in at -$18.8 million for Q1 2026 at Assertio Holdings, down from -$11.7 million in the prior quarter.
- In the past five years, EBT ranged from a high of $12.3 million in Q2 2023 to a low of -$228.9 million in Q3 2023.
- The 5-year median for EBT is -$4.4 million (2024), against an average of -$17.2 million.
- Across the five-year window, EBT slumped 5320.92% in 2023 and jumped 496.18% in 2025, its largest moves.
- Assertio Holdings' EBT stood at $8.6 million in 2022, then slumped by 471.94% to -$31.9 million in 2023, then soared by 66.31% to -$10.7 million in 2024, then fell by 9.28% to -$11.7 million in 2025, then sank by 60.15% to -$18.8 million in 2026.
- The last three EBT figures came in at -$18.8 million (Q1 2026), -$11.7 million (Q4 2025), and $11.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 437.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 758.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 318.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 17.47 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 246.80 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 87.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -61.93 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 156.41 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -101.55 Mn |
| 10 | Assertio Holdings | 150.78 Mn | 79.21 Mn | 7.22 Mn | -18.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.81 Mn |
| Dec 31, 2025 | -11.75 Mn |
| Sep 30, 2025 | 11.40 Mn |
| Jun 30, 2025 | -16.30 Mn |
| Mar 31, 2025 | -13.30 Mn |
| Dec 31, 2024 | -10.75 Mn |
| Sep 30, 2024 | -2.88 Mn |
| Jun 30, 2024 | -3.53 Mn |
| Mar 31, 2024 | -4.38 Mn |
| Dec 31, 2023 | -31.91 Mn |
| Sep 30, 2023 | -228.89 Mn |
| Jun 30, 2023 | 12.33 Mn |
| Mar 31, 2023 | -5.59 Mn |
| Dec 31, 2022 | 8.58 Mn |
| Sep 30, 2022 | 4.38 Mn |
| Jun 30, 2022 | 8.43 Mn |
| Mar 31, 2022 | 9.78 Mn |
| Dec 31, 2021 | 5.04 Mn |
| Sep 30, 2021 | 3.78 Mn |
| Jun 30, 2021 | -14.47 Mn |